Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6823
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER ; volume:22 ; number:1 ; day:26 ; month:4 ; year:2022 ; pages:1-7 ; date:12.2022
BMC endocrine disorders ; 22, Heft 1 (26.4.2022), 1-7, 12.2022
- Creator
-
Arnold, Suzanne V.
Tang, Fengming
Cooper, Andrew
Chen, Hungta
Gomes, Marilia B.
Rathmann, Wolfgang
Shimomura, Iichiro
Vora, Jiten
Watada, Hirotaka
Khunti, Kamlesh
Kosiborod, Mikhail N.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12902-022-01026-2
- URN
-
urn:nbn:de:101:1-2022070907030905291218
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Arnold, Suzanne V.
- Tang, Fengming
- Cooper, Andrew
- Chen, Hungta
- Gomes, Marilia B.
- Rathmann, Wolfgang
- Shimomura, Iichiro
- Vora, Jiten
- Watada, Hirotaka
- Khunti, Kamlesh
- Kosiborod, Mikhail N.
- SpringerLink (Online service)
Other Objects (12)
Diabetes and the COVID-19 pandemic
Deprescribing, Polypharmacy and Prescribing Cascades in Older People with Type 2 Diabetes: A Focused Review
The Standard of Care in Type 2 Diabetes: Re-evaluating the Treatment Paradigm
Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus
The Role of Real-World Evidence in Treatment Decision-Making, Regulatory Assessment, and Understanding the Perspectives of People with Type 2 Diabetes: Examples with Gliclazide MR
Early Identification and Management of Chronic Kidney Disease: A Narrative Review of the Crucial Role of Primary Care Practitioners
Education and self-management for women with polycystic ovary syndrome; a narrative review of literature
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes
Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk
Cardiorenal Protection: Potential of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes
Deprescribing in cardiometabolic conditions in older patients: a systematic review
Serum C-reactive protein increases the risk of venous thromboembolism: a prospective study and meta-analysis of published prospective evidence
Diabetes and the COVID-19 pandemic
Deprescribing, Polypharmacy and Prescribing Cascades in Older People with Type 2 Diabetes: A Focused Review
The Standard of Care in Type 2 Diabetes: Re-evaluating the Treatment Paradigm
Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus
The Role of Real-World Evidence in Treatment Decision-Making, Regulatory Assessment, and Understanding the Perspectives of People with Type 2 Diabetes: Examples with Gliclazide MR
Early Identification and Management of Chronic Kidney Disease: A Narrative Review of the Crucial Role of Primary Care Practitioners
Education and self-management for women with polycystic ovary syndrome; a narrative review of literature
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes
Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk
Cardiorenal Protection: Potential of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes
Deprescribing in cardiometabolic conditions in older patients: a systematic review
Serum C-reactive protein increases the risk of venous thromboembolism: a prospective study and meta-analysis of published prospective evidence
Diabetes and the COVID-19 pandemic
Deprescribing, Polypharmacy and Prescribing Cascades in Older People with Type 2 Diabetes: A Focused Review
The Standard of Care in Type 2 Diabetes: Re-evaluating the Treatment Paradigm
Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus
The Role of Real-World Evidence in Treatment Decision-Making, Regulatory Assessment, and Understanding the Perspectives of People with Type 2 Diabetes: Examples with Gliclazide MR
Early Identification and Management of Chronic Kidney Disease: A Narrative Review of the Crucial Role of Primary Care Practitioners
Education and self-management for women with polycystic ovary syndrome; a narrative review of literature
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes
Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk
Cardiorenal Protection: Potential of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes
Deprescribing in cardiometabolic conditions in older patients: a systematic review